Top Fund Managers

Latest Mutual Fund News

Financial Advisor Sponsor:Philip A. White

Bookmark this site!

(Enter Stock Symbol)

Partner Sites

Annuities
Wall Street Journal
eHealthInsurance

Fund Mojo on Facebook

Fund Mojo provides investors and financial advisors with deep financial intelligence through systematic data collection, correlation and analysis, as well as a community and gateway to connect investors with peers and financial experts to help each other with investments and financial planning needs.

Latest Financial News on ISIS Stock

News for ISIS Pharmaceuticals, Inc. - Google Finance

Genzyme Corporation And Isis Pharmaceuticals Announce Data From Phase 3 Study Of Mipomersen In Patients With Homozygous Familial Hypercholesterolemia Were Published [March 15 2010 06:04 AM]
Market Report -- In Play () [March 17 2010 06:07 AM]
Mipomersen Phase 3 Study in HoFH Patients Featured in The Lancet [March 13 2010 05:10 PM]
Stock News on Rising Drug Stocks (MRK, ALKS, ISIS, MYGN, MBRK) [March 15 2010 03:00 PM]
Isis Earns $6 Million Milestone Payment From Bristol-Myers Squibb for BMS-PCSK9Rx [March 12 2010 10:47 AM]

MSN Money News - ISIS - ISIS Pharmaceuticals, Inc. (ISIS)

Market Report -- In Play (ISIS) [March 8 2010 07:01 AM]
Isis Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference [March 17 2010 07:00 AM]
Regulus Announces U.S. Allowance of Stanford Patent Application Covering miR-181a Function in Immune Cells [March 17 2010 08:00 AM]
S&P 600 Snaps Win Streak [March 15 2010 05:20 PM]
5 Stocks Approaching Greatness [March 9 2010 11:34 AM]

BloggingStocks - ISIS Pharmaceuticals, Inc. (ISIS)

No current ISIS Stock news

Yahoo! Finance: ISIS News - ISIS Pharmaceuticals, Inc. (ISIS)

Blogs on ISIS Stock

Loading related blogs on ISIS Stock

Mutual Funds Impacted by ISIS Stock

Complete List : S&P 500 | Russell 3000 | ETF

Data is provided for informational purposes only, and is not intended for trading purposes. Although data are gathered from sources believed to be reliable, Fund Mojo and its content providers cannot guarantee completeness and accuracy. Performance data quoted represents past performance. Fund Mojo and its content providers accept no liability for reliance on this data.